Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Danish Warfarin-Dialysis Study
NCT03862859Phase 4Recruiting
- Start
- Oct 2019
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of warfarin in Atrial fibrillation (AFib) (2 arms). Primary endpoints: Number of participants with transient ischemic attack, fatal and non-fatal ischaemic or unspecific stroke at 4 years and Number of participants with fatal or non-fatal major bleeding at 4 years. Started Oct 2019; status: recruiting.
02
Drugs
warfarin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03862859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03862859.